US2013115641A1PendingUtilityA1

Isolated luciferases and the use thereof

54
Assignee: GOLZ STEFANPriority: Nov 23, 2000Filed: Jul 18, 2012Published: May 9, 2013
Est. expiryNov 23, 2020(expired)· nominal 20-yr term from priority
C12N 9/0069C12Y 113/12007G01N 2333/90241C12N 15/52
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A DNA or RNA molecule having the sequence for the luciferase LuAL, Lul 64, Lul 6, Lu39, Lu45, Lu52 or Lu22 or a functional equivalent thereof. 
     
     
         2 . A molecule as claimed in  claim 1 , in which the sequence contains a functional promoter located 5′ to the sequence. 
     
     
         3 . A molecule as claimed in  claim 2  which is a component of a recombinant DNA or RNA vector. 
     
     
         4 . An organism which harbors a vector as described in  claim 3 . 
     
     
         5 . An oligonucleotide which contains more than 10 consecutive nucleotides which are identical or complementary to the DNA or RNA sequence. 
     
     
         6 . A peptide which is encoded by a nucleotide sequence as claimed in  claim 1 . 
     
     
         7 . A peptide which contains more than 5 consecutive amino acids which are immunologically recognized by antibodies directed against Lul 64, LuAL or Lu22. 
     
     
         8 . The use of the luciferases as claimed in  claim 1  as reporter genes for cellular systems.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.